UncategorizedNRG Therapeutics recruits senior leadership to drive NRG5051 clinical launch – Longevity.Technology Empower Meds / October 24, 2025
UncategorizedIsaac Health partners with LillyDirect to broaden Alzheimer’s specialist care access – Longevity.Technology Empower Meds / October 24, 2025
UncategorizedImmortal Dragons backs Unlimited Bio in strategic longevity investment – Longevity.Technology Empower Meds / October 24, 2025
UncategorizedNanoscope shows 3-year vision gains in study of MCO-010 for retinitis pigmentosa – Longevity.Technology Empower Meds / October 24, 2025
UncategorizedDerisking clinical trials requires a ‘human first’ approach Empower Meds / October 23, 2025
UncategorizedTruDiagnostic links Ozempic ingredient to slower biological aging – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedCND Life Sciences receives $3 million NIH grant for Parkinson’s risk study – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedAlector halts latozinemab programme after phase 3 fails key clinical endpoint – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedLifeist relaunches Mikra products on Amazon to boost U.S. access – Longevity.Technology Empower Meds / October 23, 2025
